With the development of IVT methods, synthetic mRNA has become an emerging class of gene therapy. Generally, IVT mRNA does not require nuclear localization to mediate protein translation. Due to its safety and high efficacy, IVT mRNA has emerged as a particularly attractive gene expression system for regenerative medicine, vaccination, cell engineering, and protein replacement therapy. Learn more: mRNA IVT Synthesis